BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1392324)

  • 21. T1 breast cancer: identification of patients at low risk of axillary lymph node metastases.
    Bader AA; Tio J; Petru E; Bühner M; Pfahlberg A; Volkholz H; Tulusan AH
    Breast Cancer Res Treat; 2002 Nov; 76(1):11-7. PubMed ID: 12408371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers.
    Guarnieri A; Neri A; Correale PP; Lottini M; Testa M; Mariani F; Tucci E; Megha T; Cintorino M; Carli A
    Eur J Surg; 2001 Apr; 167(4):255-9. PubMed ID: 11354316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses.
    Gann PH; Colilla SA; Gapstur SM; Winchester DJ; Winchester DP
    Cancer; 1999 Oct; 86(8):1511-9. PubMed ID: 10526280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
    Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
    Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of p53 protein and lymph node metastases in invasive breast cancer.
    Noguchi M; Kitagawa H; Kinoshita K; Thomas M; Miyazaki I; Saito Y; Mizukami Y; Nonomura A; Michigishi T; Nakamura S
    Surg Today; 1994; 24(6):512-7. PubMed ID: 7919733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis.
    Chadha M; Chabon AB; Friedmann P; Vikram B
    Cancer; 1994 Jan; 73(2):350-3. PubMed ID: 8293399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
    Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
    Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival.
    Yuan J; Hennessy C; Corbett IP; Dykin R; Givan AL; Shenton BK; Henry JA; Wright C; Lennard TW
    Br J Surg; 1991 Jul; 78(7):844-8. PubMed ID: 1678669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.
    Hasebe T; Tsuda H; Tsubono Y; Imoto S; Mukai K
    Jpn J Cancer Res; 1997 Jun; 88(6):590-9. PubMed ID: 9263537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
    Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of the axillary lymph node status in mammary cancer on the basis of clinicopathological data and flow cytometry.
    Mattfeldt T; Kestler HA; Sinn HP
    Med Biol Eng Comput; 2004 Nov; 42(6):733-9. PubMed ID: 15587463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult axillary lymph node metastases are of no prognostic significance in breast cancer.
    Millis RR; Springall R; Lee AH; Ryder K; Rytina ER; Fentiman IS
    Br J Cancer; 2002 Feb; 86(3):396-401. PubMed ID: 11875706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer.
    Lauria R; Perrone F; Carlomagno C; De Laurentiis M; Morabito A; Gallo C; Varriale E; Pettinato G; Panico L; Petrella G
    Cancer; 1995 Nov; 76(10):1772-8. PubMed ID: 8625046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.